Developer docs
API playgroundTry for free, no card

Search company profiles

Resilience

Full company profile

uuid0000im7

Namestring
Resilience
Legal namestring
RESILIENCE SAS
Websiteurl
resilience.care
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Resilience (legal entity RESILIENCE SAS, operating as Resilience Care) is a French digital health company founded in February 2021 and headquartered in Paris that builds a digital oncology platform for remote patient monitoring. Its core medical device, Resilience PRO, is a CE 0459-marked Class IIa product that captures patient-reported symptoms and adverse events in real time and triggers automated safety alerts to oncology care teams; it is reimbursed by the French Assurance Maladie and integrated with hospital information systems via InterSystems IRIS for Health (production deployment from October 2025). The platform is complemented by the Resilience Care patient mobile application and additional modules — Advanced Analytics Platform, Advanced Clinical & Biological Data Structuring (AI-assisted), Evidence Generation Hub, and Real-World Data Explorer — and extends into gastroenterology (GutyCare) and psychiatry (Edra PRO), with manufacturing handled through wholly-owned subsidiary Resilience MD SAS in Biarritz.

The company monetizes Resilience PRO through healthcare institution subscriptions and French national reimbursement, while selling data, analytics, and real-world evidence services to pharmaceutical and biotech customers via the Evidence Generation Hub and Real-World Data Explorer. Resilience sells primarily through a direct enterprise sales motion targeting oncology centers and hospitals, and serves 200+ healthcare institutions, 1,500+ healthcare providers, and 35,000+ monitored patients across France, Belgium, and Germany, with announced expansion into the United States in March 2026 led by General Manager Greg Orr. Cumulative disclosed funding totals approximately $76 million across a 2021 seed, 2022 Series A led by Cathay Innovation with strategic participation from EXOR and hospital investors, and a 2024 round led by Picus Capital and Red River West, alongside acquisitions of Ana Health (2022) and GIMLI (2024).

Short descriptiontext

Resilience Care is a French digital health company (Paris, founded 2021) that sells a CE-marked remote patient monitoring platform for oncology, gastroenterology, and psychiatry, serving 200+ hospitals and life sciences customers across Europe and expanding into the U.S.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote patient monitoring, digital oncology platform, clinical decision support, real-world evidence generation, medical device software
Industry3 codes
PRIMARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAGAH
Oncology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code1 code
  • Home Health Care Services62161
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Digital Health / Remote Patient Monitoring
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Remote Patient Monitoring (Resilience PRO)
TypeSubscription Recurring
Description

Resilience PRO, a Class IIa medical device for remote patient monitoring of cancer patients, is reimbursed by French Assurance Maladie (French national social security system). Revenue is generated through healthcare institution subscriptions and government reimbursement pathways.

news.pedaily.cn
2Life Sciences Solutions
TypeSubscription Recurring
Description

Platform services for pharmaceutical and biotech companies to inform drug development, transform clinical trials, and accelerate real-world evidence generation. Revenue from research partnerships and data access agreements.

resilience.care
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Healthcare institution subscription with French national reimbursement
ModelSubscriptionBilling cadenceAnnual
Notes

Resilience PRO is a Class IIa medical device (CE 0459 mark) reimbursed by the French Assurance Maladie system. Pricing for life sciences and international markets is quote-based.

news.pedaily.cn
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Resilience PRO
Description

Remote patient monitoring solution indicated for oncology patients to monitor adverse events and adapt patient management. Class IIa medical device with CE 0459 marking, reimbursed by French Social Security.

patients.resilience.care
+2 more records
Core offering1 text field

Resilience provides a CE-marked Class IIa digital oncology platform for remote patient monitoring of cancer patients, comprising the Resilience PRO monitoring medical device and the Resilience Care companion app. The platform captures real-time patient-reported symptoms and adverse events with automated alerts, structures clinical and biological data, and supports real-world evidence generation for healthcare providers and life sciences companies across oncology, gastroenterology, and psychiatry.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 200+ healthcare institutions using the platform
+3 more records
Product overview1 text field

Resilience offers a multi-module digital oncology platform with specialized solutions for oncology, gastroenterology, and psychiatry. The core platform consists of Resilience PRO (remote patient monitoring module for oncology) and the Resilience Care App (patient-centric companion application), supported by add-on modules including the Advanced Analytics Platform, Advanced Clinical & Biological Data Structuring (AI-powered), Evidence Generation Hub, and Real-World Data Explorer. The company also offers specialized sub-brands: GutyCare for gastroenterology and Edra PRO for psychiatry. All medical devices are Class IIa with CE 0459 marking. The platform integrates with hospital information systems via InterSystems IRIS and supports 200+ healthcare institutions monitoring 35,000+ patients across Europe and expanding to the U.S.

Product and service8 records
1Resilience PRO
CategoryRemote Patient Monitoring Medical Device
Description

Class IIa CE-marked medical device for remote patient monitoring of oncology patients, tracking symptoms and adverse events in real time with automated safety alerts to healthcare providers. Reimbursed by French Assurance Maladie.

2Resilience Care App
CategoryPatient Companion Application
Description

Patient-centric mobile application providing personalized programs and content tailored to each patient's pathology, treatment, and symptoms, enabling continuous digital support and early symptom detection across oncology, gastroenterology, and psychiatry.

3Advanced Analytics Platform
CategoryHealthcare Analytics Software
Description

Intuitive dashboards for data-driven decision-making in clinical operations, enabling healthcare providers to monitor patient outcomes, identify trends, and improve care quality.

4Advanced Clinical & Biological Data Structuring
CategoryAI-Powered Clinical Data Software
Description

AI-powered capability that structures fragmented clinical and biological data into actionable insights for clinical research, market access, publications, and improved patient stratification for precision medicine.

5Evidence Generation Hub
CategoryReal-World Evidence Platform
Description

End-to-end platform for designing and running real-world evidence studies, enabling life sciences companies to demonstrate treatment value and patient outcomes.

6Real-World Data Explorer
CategoryReal-World Data Analytics
Description

Secure access to aggregated, de-identified data from the Resilience partner network, enabling real-time exploration and advanced analytics for clinical research purposes.

7GutyCare
CategoryGastroenterology Remote Monitoring
Description

Class IIa CE-marked remote medical monitoring platform for gastroenterology, enabling specialist nurses to interpret health data and adapt patient care. Not reimbursed by French Assurance Maladie.

8Edra PRO
CategoryPsychiatry Remote Monitoring
Description

Class IIa CE-marked remote monitoring and clinical decision support platform in psychiatry for adult patients experiencing major depressive or manic episodes, excluding emergency situations.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-03-03
Description

Technology partnership to deploy oncology care solution using InterSystems IRIS for Health as integration layer with hospital information systems. Enables automatic synchronization of chemotherapy appointments, consultations, and lab tests while eliminating duplicate entries. Production began October 2025 with deployment underway in several healthcare facilities. Plans to extend solution to gastroenterology, psychiatry, and additional hospitals.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Finnish digital health platform providing remote symptom monitoring for cancer patients, now part of Elekta. Directly comparable to Resilience in oncology-focused RPM, ePRO capture, and hospital integration.

TypeDirect peer
Description

Oncology patient engagement and symptom monitoring platform, now part of Varian (a Siemens Healthineers company). Competes with Resilience in delivering ePRO-based RPM to cancer centers and life sciences partners.

TypeDirect peer
Description

French digital health company focused on remote monitoring and care pathways for cancer patients. Closest direct French peer to Resilience, serving similar oncology provider customers.

TypeDirect peer
Description

France-based digital therapeutics company developing CE-marked software for chronic disease and oncology patient monitoring. Comparable regulatory pathway (Class IIa CE marking) and similar pharma partnership model.

5Tempus Labs
TypeBroad incumbent
Description

U.S.-based oncology data and AI company operating a large real-world evidence platform. Comparable to Resilience's life sciences offering through structured oncology data and pharma/biotech partnerships, though at much greater scale.

TypeBroad incumbent
Description

Oncology-focused electronic health record and real-world data company (acquired by Roche). Comparable in oncology RWE monetization and clinical workflow integration with U.S. cancer centers.

TypeBroad incumbent
Description

Global medtech incumbent offering RPM solutions across multiple therapy areas including oncology. Competes with Resilience on enterprise hospital deals and broader care continuum.

TypeBroad incumbent
Description

Large-scale virtual care and chronic condition management platform. Adjacent in remote monitoring and chronic care, though broader and less oncology-specialized than Resilience.

TypeEmerging player
Description

Digital health platform offering remote patient monitoring and decentralized clinical trial capabilities across multiple therapy areas. Comparable in RPM + DCT play, with stronger U.S. and pharma presence.

TypeOthers
Description

Healthcare data platform provider; Resilience's technology integration partner via IRIS for Health. Relevant as a strategic enabler of hospital EHR integration and adjacent ecosystem participant.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Resilience

Digital Health / Remote Patient Monitoringresilience.care

Resilience Care is a French digital health company (Paris, founded 2021) that sells a CE-marked remote patient monitoring platform for oncology, gastroenterology, and psychiatry, serving 200+ hospitals and life sciences customers across Europe and expanding into the U.S.

What Resilience does

Resilience (legal entity RESILIENCE SAS, operating as Resilience Care) is a French digital health company founded in February 2021 and headquartered in Paris that builds a digital oncology platform for remote patient monitoring. Its core medical device, Resilience PRO, is a CE 0459-marked Class IIa product that captures patient-reported symptoms and adverse events in real time and triggers automated safety alerts to oncology care teams; it is reimbursed by the French Assurance Maladie and integrated with hospital information systems via InterSystems IRIS for Health (production deployment from October 2025). The platform is complemented by the Resilience Care patient mobile application and additional modules — Advanced Analytics Platform, Advanced Clinical & Biological Data Structuring (AI-assisted), Evidence Generation Hub, and Real-World Data Explorer — and extends into gastroenterology (GutyCare) and psychiatry (Edra PRO), with manufacturing handled through wholly-owned subsidiary Resilience MD SAS in Biarritz.

The company monetizes Resilience PRO through healthcare institution subscriptions and French national reimbursement, while selling data, analytics, and real-world evidence services to pharmaceutical and biotech customers via the Evidence Generation Hub and Real-World Data Explorer. Resilience sells primarily through a direct enterprise sales motion targeting oncology centers and hospitals, and serves 200+ healthcare institutions, 1,500+ healthcare providers, and 35,000+ monitored patients across France, Belgium, and Germany, with announced expansion into the United States in March 2026 led by General Manager Greg Orr. Cumulative disclosed funding totals approximately $76 million across a 2021 seed, 2022 Series A led by Cathay Innovation with strategic participation from EXOR and hospital investors, and a 2024 round led by Picus Capital and Red River West, alongside acquisitions of Ana Health (2022) and GIMLI (2024).

Resilience firmographics

Firmographics
Name
Resilience
Legal name
RESILIENCE SAS
Website
https://resilience.care
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
101–250 employees
Short description
Resilience Care is a French digital health company (Paris, founded 2021) that sells a CE-marked remote patient monitoring platform for oncology, gastroenterology, and psychiatry, serving 200+ hospitals and life sciences customers across Europe and expanding into the U.S.
Ownership category
akta.pro rank

Resilience industry classification

Industry
Product category
Digital Health / Remote Patient Monitoring
NAICS
Home Health Care Services (62161)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAGAH
Oncology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Remote patient monitoring
  • Digital oncology platform
  • Clinical decision support
  • Real-world evidence generation
  • Medical device software

Where Resilience is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices3 records

Markets served

Resilience business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Remote Patient Monitoring (Resilience PRO): Resilience PRO, a Class IIa medical device for remote patient monitoring of cancer patients, is reimbursed by French Assurance Maladie (French national social security system). Revenue is generated through healthcare institution subscriptions and government reimbursement pathways.
  2. Life Sciences Solutions: Platform services for pharmaceutical and biotech companies to inform drug development, transform clinical trials, and accelerate real-world evidence generation. Revenue from research partnerships and data access agreements.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualHealthcare institution subscription with French national reimbursement

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Resilience product offering

Product offering

Core offering

Resilience provides a CE-marked Class IIa digital oncology platform for remote patient monitoring of cancer patients, comprising the Resilience PRO monitoring medical device and the Resilience Care companion app. The platform captures real-time patient-reported symptoms and adverse events with automated alerts, structures clinical and biological data, and supports real-world evidence generation for healthcare providers and life sciences companies across oncology, gastroenterology, and psychiatry.

Product overview

Resilience offers a multi-module digital oncology platform with specialized solutions for oncology, gastroenterology, and psychiatry. The core platform consists of Resilience PRO (remote patient monitoring module for oncology) and the Resilience Care App (patient-centric companion application), supported by add-on modules including the Advanced Analytics Platform, Advanced Clinical & Biological Data Structuring (AI-powered), Evidence Generation Hub, and Real-World Data Explorer. The company also offers specialized sub-brands: GutyCare for gastroenterology and Edra PRO for psychiatry. All medical devices are Class IIa with CE 0459 marking. The platform integrates with hospital information systems via InterSystems IRIS and supports 200+ healthcare institutions monitoring 35,000+ patients across Europe and expanding to the U.S.

Differentiator

Problem solved

Functional benefit

Brands

  • Resilience PRO: Remote patient monitoring solution indicated for oncology patients to monitor adverse events and adapt patient management. Class IIa medical device with CE 0459 marking, reimbursed by French Social Security.
  • GutyCare
  • Edra PRO

Products and services

  • Resilience PRO Class IIa CE-marked medical device for remote patient monitoring of oncology patients, tracking symptoms and adverse events in real time with automated safety alerts to healthcare providers. Reimbursed by French Assurance Maladie.
  • Resilience Care App Patient-centric mobile application providing personalized programs and content tailored to each patient's pathology, treatment, and symptoms, enabling continuous digital support and early symptom detection across oncology, gastroenterology, and psychiatry.
  • Advanced Analytics Platform Intuitive dashboards for data-driven decision-making in clinical operations, enabling healthcare providers to monitor patient outcomes, identify trends, and improve care quality.
  • Advanced Clinical & Biological Data Structuring AI-powered capability that structures fragmented clinical and biological data into actionable insights for clinical research, market access, publications, and improved patient stratification for precision medicine.
  • Evidence Generation Hub End-to-end platform for designing and running real-world evidence studies, enabling life sciences companies to demonstrate treatment value and patient outcomes.
  • Real-World Data Explorer Secure access to aggregated, de-identified data from the Resilience partner network, enabling real-time exploration and advanced analytics for clinical research purposes.
  • GutyCare Class IIa CE-marked remote medical monitoring platform for gastroenterology, enabling specialist nurses to interpret health data and adapt patient care. Not reimbursed by French Assurance Maladie.
  • Edra PRO Class IIa CE-marked remote monitoring and clinical decision support platform in psychiatry for adult patients experiencing major depressive or manic episodes, excluding emergency situations.

Quantifiable outcome

  • 200+ healthcare institutions using the platform
  • +3 more outcomes

Companies that use Resilience

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles2 records

Resilience technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability5 records

Feature7 records

Resilience partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • InterSystemscoreTechnology or Integration · 3 March 2026Technology partnership to deploy oncology care solution using InterSystems IRIS for Health as integration layer with hospital information systems. Enables automatic synchronization of chemotherapy appointments, consultations, and lab tests while eliminating duplicate entries. Production began October 2025 with deployment underway in several healthcare facilities. Plans to extend solution to gastroenterology, psychiatry, and additional hospitals.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Resilience competitors and assessment

Company assessment

Direct peers

  • Kaiku Health: Finnish digital health platform providing remote symptom monitoring for cancer patients, now part of Elekta. Directly comparable to Resilience in oncology-focused RPM, ePRO capture, and hospital integration.
  • Noona: Oncology patient engagement and symptom monitoring platform, now part of Varian (a Siemens Healthineers company). Competes with Resilience in delivering ePRO-based RPM to cancer centers and life sciences partners.
  • Cureety: French digital health company focused on remote monitoring and care pathways for cancer patients. Closest direct French peer to Resilience, serving similar oncology provider customers.
  • Voluntis: France-based digital therapeutics company developing CE-marked software for chronic disease and oncology patient monitoring. Comparable regulatory pathway (Class IIa CE marking) and similar pharma partnership model.

Broad incumbents

  • Tempus Labs: U.S.-based oncology data and AI company operating a large real-world evidence platform. Comparable to Resilience's life sciences offering through structured oncology data and pharma/biotech partnerships, though at much greater scale.
  • Flatiron Health: Oncology-focused electronic health record and real-world data company (acquired by Roche). Comparable in oncology RWE monetization and clinical workflow integration with U.S. cancer centers.
  • Philips (Remote Patient Monitoring): Global medtech incumbent offering RPM solutions across multiple therapy areas including oncology. Competes with Resilience on enterprise hospital deals and broader care continuum.
  • Teladoc Health: Large-scale virtual care and chronic condition management platform. Adjacent in remote monitoring and chronic care, though broader and less oncology-specialized than Resilience.

Emerging players

  • Huma (formerly Medopad): Digital health platform offering remote patient monitoring and decentralized clinical trial capabilities across multiple therapy areas. Comparable in RPM + DCT play, with stronger U.S. and pharma presence.

Others

  • InterSystems: Healthcare data platform provider; Resilience's technology integration partner via IRIS for Health. Relevant as a strategic enabler of hospital EHR integration and adjacent ecosystem participant.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Resilience social profiles

Digital presence

Resilience compliance and trust

Trust signal

Compliance2 records

Resilience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Resilience leadership team

Management profile

Number of profiles

Profiles6 records

Resilience subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Resilience funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Resilience M&A and investment

M&A and investment

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Resilience

What does Resilience do?

Resilience provides a CE-marked Class IIa digital oncology platform for remote patient monitoring of cancer patients, comprising the Resilience PRO monitoring medical device and the Resilience Care companion app. The platform captures real-time patient-reported symptoms and adverse events with automated alerts, structures clinical and biological data, and supports real-world evidence generation for healthcare providers and life sciences companies across oncology, gastroenterology, and psychiatry.

Is Resilience a public or private company?

Resilience is a private company. It is classified as venture growth investor backed and is currently operating.

When was Resilience founded?

Resilience was founded in 2021. It employs 101 to 250 people.

Where is Resilience based?

Resilience is headquartered in Paris, France, in the Europe region.

How does Resilience make money?

Two revenue lines are on record. Remote Patient Monitoring (Resilience PRO) is the primary driver. The others are life Sciences Solutions.

Who are Resilience's main competitors?

Direct peers on record are Kaiku Health, Noona, Cureety and Voluntis. Broad incumbents are Tempus Labs, Flatiron Health, Philips (Remote Patient Monitoring) and Teladoc Health. Huma (formerly Medopad) is listed as an emerging player. InterSystems is listed as an others.

Does Resilience have an API?

No public API is recorded for Resilience.

What industry is Resilience in?

Resilience's product category is Digital Health / Remote Patient Monitoring. Its primary akta.pro industry code is HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation, with a secondary code of HLALAGAH, Oncology Telemedicine Platforms. Its NAICS code is 62161 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Les Echos« Multipays, multipathologies » : la nouvelle aventure de Resilience Care, avec PSG Equity à son capitalResilience Care, a medical telemonitoring firm, raised 48 million euros from PSG Equity, bringing total funding to over 105 million euros. The company, founded in 2021, now plans to expand beyond oncology and beyond France, aiming to replicate its French cancer model in other specialties and health systems.FRENCHWEB.FRAvec Recovery Cat, RESILIENCE CARE achète une porte d’entrée dans la psychiatrie allemandeResilience Care acquired Berlin-based Recovery Cat, a psychiatric telemonitoring platform used in nearly 20 hospitals and clinics. The deal includes a contract with Germany's Techniker Krankenkasse, covering 12.5 million insured, allowing free access for TK patients. The acquisition expands Resilience's presence in German psychiatry.MaddynessComment 50 Partners accélère dans la santé50 Partners launched its health accelerator in 2021, selecting six to seven startups annually. French healthtech funding rose 15% in 2025 to €1.028 billion, and the accelerator launched an investment fund. The program emphasizes regulatory and operational support for founders.The Real DealRialto’s $34M foreclosure targets shuttered Chicago-area medical empire caught in Patlola vs. Prasad feudRialto Capital Advisors filed a foreclosure complaint in Cook County against Clarendon Realty and River Forest Realty, entities controlled by Rathnaker Patlola, over a $34 million CMBS loan. The claim includes a $6.2 million yield maintenance premium and $1.4 million in default interest, with interest accruing at over $8,560 daily. A hearing is set for December.BioSpaceLIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.LIR Life Sciences entered a Technology Development Collaboration Agreement with Resilience BioSciences to support its preclinical research. LIR will pay $5,000 per month under a six-month term, conducting ex vivo porcine skin and formulation studies at RBI's UBC facilities. The collaboration aims to advance LIR's transdermal patch for obesity.PR NewswireResilience Care Expands to U.S. Market, Adds Veteran Digital Health Leaders to Support Growth with Oncology ProvidersResilience Care, a digital oncology company co-founded with Gustave Roussy Institute, announced its formal expansion into the United States on March 31, 2026, bringing its continuous cancer care platform to American healthcare providers after establishing it as standard care across Europe in over 200 clinical centers serving more than 35,000 patients. The company appointed Greg Orr, former COO and CCO of Jasper Health, as General Manager to lead U.S. operations, and assembled an advisory board of digital health and oncology veterans including Eddie Martucci (co-founder of Akili Interactive) and Jill DeSimone (former President of U.S. Oncology at Merck). The platform's evidence-based approach has demonstrated a 38% reduction in hospitalizations and sustains an 85% patient adherence rate after one year of use.Business Wire BlogResilience Care & InterSystems Partner to Streamline Oncology Care PathwaysResilience Care, a French remote medical monitoring company, announced a technology partnership with InterSystems to deploy its oncology care solution using InterSystems IRIS for Health as an integration layer with hospital information systems. The partnership enables automatic synchronization of chemotherapy appointments, consultations, and lab tests while eliminating duplicate entries, freeing healthcare teams to focus on patient monitoring. Production began in October 2025 with deployment already underway in several healthcare facilities, with plans to extend the solution to gastroenterology, psychiatry, and additional hospitals and clinics.EsmoAI and remote monitoring are shaping a new patient journey in oncologyResilience, a remote patient-monitoring solution developer, is integrating artificial intelligence and acquired natural language processing technology from Gimli to enhance oncology care workflows and predict adverse events. The company has deployed its digital tools across healthcare institutions in France, Belgium, Germany, and Spain, collecting real-world data from over 20,000 patients to improve symptom tracking and clinical research capabilities.FRENCHWEB.FRRESILIENCE fait l’acquisition de GIMLI pour personnaliser les soins en oncologie grâce à l’IAResilience acquired GIMLI, a French startup founded in 2022 by oncologist Alexandre Yazigi and data expert Anthony Dubois. GIMLI uses NLP and machine learning to standardize unstructured medical reports, which Resilience will deploy across its 100 health establishments. The acquisition aims to personalize care and accelerate clinical research.